Troy Edward Wilson, President and CEO of Kura Oncology, Inc., filed a Form 4/A amendment on November 17, 2026, correcting the ownership classification of two open-market purchases of Kura Oncology common stock made on November 13 and November 16, 2026.

Key Highlights

  • Amendment purpose: The filing corrects the ownership form of two purchases, reclassifying them from direct to indirect ownership held through the One Fish Two Fish Revocable Trust.
  • November 13 purchase: 98,881 shares acquired at a weighted average price of $7.63 per share, with individual trade prices ranging from $7.47 to $7.79.
  • November 16 purchase: 101,119 shares acquired at a weighted average price of $7.42 per share, with individual trade prices ranging from $7.27 to $7.73.
  • Indirect holdings after transactions: 679,194 shares held indirectly through the One Fish Two Fish Revocable Trust.
  • Direct holdings: 435,456 shares held directly by the reporting person following the reported transactions.
  • Additional indirect holdings: 300,000 shares held indirectly through the Lorax Charitable Remainder Unitrust.
  • Unchanged elements: According to the filing, "The transaction dates, quantities, prices and aggregate beneficial ownership are unchanged."

Kura Oncology CEO Wilson Amends Filing to Reflect Trust-Held Share Purchases

According to the Form 4/A filed on November 17, 2026, Troy Edward Wilson, who serves as both a Director and President and CEO of Kura Oncology, Inc. (NASDAQ:KURA), amended an original Form 4 filed on November 16, 2026. The amendment corrects only the ownership classification of the two reported purchases, changing them from direct to indirect, as the transactions were executed through the One Fish Two Fish Revocable Trust.

The filing discloses that on November 13, 2026, Wilson acquired 98,881 shares of common stock at a weighted average purchase price of $7.63, with individual trades priced between $7.47 and $7.79. On November 16, 2026, an additional 101,119 shares were acquired at a weighted average price of $7.42, with trades ranging from $7.27 to $7.73. Both transactions carry a transaction code of "P," indicating open-market purchases. The filing notes that full detail on individual trade prices is available upon request to the SEC staff, the issuer, or a security holder.

Following both transactions, the filing reports that Wilson held 679,194 shares indirectly through the One Fish Two Fish Revocable Trust, 300,000 shares indirectly through the Lorax Charitable Remainder Unitrust, and 435,456 shares directly. The filing was signed by Teresa Bair as attorney-in-fact for Troy E. Wilson on November 17, 2026.

What Was Disclosed

This Form 4/A amends a November 16, 2026 filing to correct the ownership form of two purchases totaling 200,000 shares, reclassifying them as indirect holdings through the One Fish Two Fish Revocable Trust. All other transaction details remain unchanged.